Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan introduces generic Boniva injection
The US Food and Drug Administration (FDA) had granted clearance for Mylan’s abbreviated new drug application (ANDA) for this product, which is indicated to treat osteoporosis in postmenopausal
The US Food and Drug Administration (FDA) had granted clearance for Mylan’s abbreviated new drug application (ANDA) for this product, which is indicated to treat osteoporosis in postmenopausal
Under the deal, Meiji will start promotional activities for Rozerem on 01 October, targeting psychiatric institutions covered by MRs fully dedicated to the CNS field. Currently, the melatonin
These two are life-threatening fungal infections predominantly occurring in immunocompromised patients. The FDA has designated the date of 8 March 2015 for the completion of the review, in
Discovered and developed by Takeda, Leuplin is an LH-RH agonist that stimulates the pituitary gland, resulting in suppressed production of male/female hormone. The NDA is based on the
The new grant will support the completion of a Phase IIa trial of MN-166 in opioid dependence, for which the company had recently released positive interim results. The
The approval was based on data from a Phase III registration program, which showed that ferric citrate reduced serum phosphorus levels to well within the KDOQI guidelines range
The indication of Keytruda 2mg/kg every three weeks is approved under accelerated approval based on tumor response rate and durability of response. Keytruda, the first anti-programmed death receptor-1
As part of the deal, Navidea will earn royalties on units sales, an upfront payment of $300,000, up to $700,000 in development milestone payments and up to $1.5m
The Public Health Agency of Canada (PHAC) has initially developed the vaccine, which is under an exclusive licensing arrangement with BioProtection Systems, a subsidiary of NewLink Genetics. The
The new patent contains a composition of matter claim covering the use of the company’s ion exchange formulation of benzonatate. Claims for using benzonatate polacrilex to reduce or